The rs5065 G allele was more frequent in patients with embolic stroke of undetermined source than other stroke etiologies (69.1% vs 62.4%; OR 1.35; 95% CI 1.01-1.80; p=0.044).
Observational (n=1,003)
No
Does the rs5065 genetic variant of the NPPA gene associate with MR-proANP levels and ESUS in patients with ischemic stroke?
1,003 patients with ischemic stroke (288 classified as ESUS, 715 as another defined etiology) enrolled at Hannover Medical School.
Presence of the dominant G allele (AG+GG) of the rs5065 genetic variant of the NPPA gene
AA genotype of the rs5065 genetic variant
Association with ESUS and MR-proANP serum concentrationsurrogate
The rs5065 G allele is enriched in patients with ESUS compared to other ischemic stroke etiologies, independent of MR-proANP levels, suggesting a potential genetic link to cardioembolic stroke risk.
Effect estimate: OR 1.35 (95% CI 1.01-1.80)
Absolute Event Rate: 69.1% vs 62.4%
p-value: p=0.044
Abstract Background and aims Mid-regional pro-atrial natriuretic peptide (MR-proANP) serves as a biomarker for cardioembolic stroke (CES). rs5065, a genetic variant of the Natriuretic Peptide A (NPPA)-gene encoding ANP, remains insufficiently studied in stroke etiologies. Within the PHEGAESUS-study, a phenotype-genotype association study investigating ESUS, we conducted a targeted biomarker analysis to evaluate the impact of rs5065 on MR-proANP and stroke etiology. Methods Between December 2020 and July 2023, patients with ischemic stroke were enrolled at Hannover Medical School. Genotyping was performed using Axiom myDesign Genotyping-Array. MR-proANP serum concentration was measured via fluorescence immunoassay, if samples were available more than 24 hours after stroke onset. Descriptive analyses were performed to elucidate an association between rs5065, MR-proANP-level and ESUS. Results After quality control, 1,003 patients with clinical and SNP-data were available (288 classified as ESUS, 715 as another defined etiology). In the dominant model (AG+GG vs AA), G allele carriers were more frequent in ESUS than in other stroke etiologies (69.1% vs 62.4%, p-chi2: 0.044, OR 1.35, 95%CI: 1.01-1.80). After adjustment for Essen Stroke Risk-Score, the association of rs5065 carrier status with higher odds of ESUS (aOR: 1.37, 95%CI: 1.02-1.84) remained. No differences of MR-proANP-level across the genotypes were observed (median (interquartile range): AG+GG n=92: 99.1 (83.8)pmol/l vs AA n=52: 91.5 (118.8) pmol/l, p Mann-Whitney-U: 0.8). Conclusions The dominant G allel of rs5065 does not seem to influence MR-proANP-level, but is enriched in ESUS patients. Investigation of NPPA-genomic region may improve better understanding of genetic variances, biomarkers and ESUS. Conflict of interest Rebecca Menkhaus: nothing to disclose, Gerrit M Grosse: nothing to disclose, Johannes Teller: nothing to disclose, Rieke Ringslstetter: nothing to disclose, Maria M Gabriel: nothing to disclose, Vinicius D Gastaldi: nothing to disclose, Hannelore Ehrenreich: nothing to disclose, Karin Weissenborn: nothing to disclose, Anika Grosshennig: nothing to disclose, Johanna Ernst: nothing to disclose
Building similarity graph...
Analyzing shared references across papers
Loading...
Rebecca Menkhaus
Medizinische Hochschule Hannover
Gerrit M. Große
University of Basel
Johannes Teller
Medizinische Hochschule Hannover
European Stroke Journal
University of Basel
Medizinische Hochschule Hannover
University Hospital of Basel
Building similarity graph...
Analyzing shared references across papers
Loading...
Menkhaus et al. (Fri,) conducted a observational in Ischemic stroke (n=1,003). rs5065 G allele carrier status (AG+GG) vs. rs5065 AA genotype was evaluated on Embolic stroke of undetermined source (ESUS) vs other defined stroke etiologies (OR 1.35, 95% CI 1.01-1.80, p=0.044). The rs5065 G allele was more frequent in patients with embolic stroke of undetermined source than other stroke etiologies (69.1% vs 62.4%; OR 1.35; 95% CI 1.01-1.80; p=0.044).
synapsesocial.com/papers/69fd7e90bfa21ec5bbf06d3c — DOI: https://doi.org/10.1093/esj/aakag023.921